Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years

Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years

Abstract Introduction Since the development of antiretroviral therapy (ART) with TDF plus 3TC plus EFV, this specific regimen has not been studied enough with long-term lipid and uric acid monitoring. Methods A prospective follow-up cohort study was performed. Sixty-one treatment-naive male patients...

Full description

Bibliographic Details
Main Authors: Dafeng Liu, Xinyi Zhang, Jun Kang, Fengjiao Gao, Yinsheng He, Shenghua He
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Human immunodeficiency virus (HIV)
Antiretroviral therapy (ART)
Lipid metabolism parameter
Uric acid
Dynamic change
Long-term
Online Access:https://doi.org/10.1186/s13098-021-00756-y

Internet

https://doi.org/10.1186/s13098-021-00756-y

Similar Items